The AmoyDx® ROS1 Gene Fusions Detection Kit is an in vitro nucleic acid amplification test intended for qualitative detection of 14 ROS1 gene fusions in human formalin-fixed paraffin-embedded (FFPE) tumor tissue RNA. The kit is intended to assess ROS1 gene status in NSCLC patients and to aid the clinician in identifying NSCLC patients who may response to ROS1 inhibitor therapy, such as Xalkori® (crizotinib).
Specifications
Tests/kit
12 (Bulk)
Instrument
Stratagene Mx3000P™, ABI 7500, LightCycler480 II,
SLAN-96S
SLAN-96S
Inquiry